Samuel Chamberlain - Publications

Affiliations: 
Department of Psychiatry University of Cambridge, Cambridge, England, United Kingdom 

98 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Reid JE, Pellegrini L, Drummond L, Varlakova Y, Shahper S, Baldwin DS, Manson C, Chamberlain SR, Robbins TW, Wellsted D, Fineberg NA. Differential effects of sertraline and cognitive behavioural therapy on behavioural inhibition in patients with obsessive compulsive disorder. International Clinical Psychopharmacology. PMID 38568112 DOI: 10.1097/YIC.0000000000000548  0.328
2023 Grant JE, Collins M, Chamberlain SR, Chesivoir E. Disorders of impulsivity in trichotillomania and skin picking disorder. Journal of Psychiatric Research. 170: 42-46. PMID 38101209 DOI: 10.1016/j.jpsychires.2023.12.011  0.3
2023 Grant JE, Chamberlain SR. Duration of untreated illness in gambling disorder. Cns Spectrums. 1-21. PMID 37694344 DOI: 10.1017/S1092852923002444  0.302
2023 Jalal B, Chamberlain SR, Sahakian BJ. Obsessive-compulsive disorder: Etiology, neuropathology, and cognitive dysfunction. Brain and Behavior. e3000. PMID 37137502 DOI: 10.1002/brb3.3000  0.753
2023 Grant JE, Chamberlain SR. Impaired Cognitive Flexibility Across Psychiatric Disorders. Cns Spectrums. 1-17. PMID 37114560 DOI: 10.1017/S1092852923002237  0.415
2023 Hook RW, Isobe M, Savulich G, Grant JE, Ioannidis K, Christmas D, Sahakian BJ, Robbins TW, Chamberlain SR. Role of adenosine A2A receptors in hot and cold cognition: Effects of single-dose istradefylline in healthy volunteers. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 71: 55-64. PMID 36989539 DOI: 10.1016/j.euroneuro.2023.03.006  0.507
2023 Aslan IH, Grant JE, Chamberlain SR. Cognition in adults with borderline personality disorder. Cns Spectrums. 1-6. PMID 36924168 DOI: 10.1017/S1092852923001177  0.426
2023 Chamberlain SR, Aslan B, Quinn A, Anilkumar A, Robinson J, Grant JE, Sinclair J. Autism and gambling: a systematic review, focusing on neurocognition. Neuroscience and Biobehavioral Reviews. 105071. PMID 36738812 DOI: 10.1016/j.neubiorev.2023.105071  0.384
2022 Grant JE, Chamberlain SR. Characteristics of 262 adults with skin picking disorder. Comprehensive Psychiatry. 117: 152338. PMID 35843137 DOI: 10.1016/j.comppsych.2022.152338  0.319
2022 Bowden-Jones H, Hook RW, Grant JE, Ioannidis K, Corazza O, Fineberg NA, Singer BF, Roberts A, Bethlehem R, Dymond S, Romero-Garcia R, Robbins TW, Cortese S, Thomas SA, Sahakian BJ, ... ... Chamberlain SR, et al. Gambling disorder in the UK: key research priorities and the urgent need for independent research funding. The Lancet. Psychiatry. PMID 35180386 DOI: 10.1016/S2215-0366(21)00356-4  0.52
2022 Sparasci O, Bhui K, Biswas A, Chamberlain S, Dubicka B, Dudas R, Farooq S, Ford T, Husain N, Jones I, Killaspy H, Lee W, Lingford-Hughes A, Mulholland C, Rubinsztein J, et al. Impact of COVID-19 on mental health research: is this the breaking point? The British Journal of Psychiatry : the Journal of Mental Science. 1-3. PMID 35172915 DOI: 10.1192/bjp.2022.8  0.716
2021 Grant JE, Valle S, Chesivoir E, Ehsan D, Chamberlain SR. A double-blind placebo-controlled study of brexpiprazole for the treatment of borderline personality disorder. The British Journal of Psychiatry : the Journal of Mental Science. 1-6. PMID 35049469 DOI: 10.1192/bjp.2021.159  0.302
2021 Isobe M, Vaghi M, Fineberg NA, Apergis-Schoute AM, Bullmore ET, Sahakian BJ, Robbins TW, Chamberlain SR. Set-shifting-related basal ganglia deformation as a novel familial marker of obsessive-compulsive disorder. The British Journal of Psychiatry : the Journal of Mental Science. 1-4. PMID 35049465 DOI: 10.1192/bjp.2021.45  0.538
2021 Stein DJ, Craske MG, Rothbaum BO, Chamberlain SR, Fineberg NA, Choi KW, de Jonge P, Baldwin DS, Maj M. The clinical characterization of the adult patient with an anxiety or related disorder aimed at personalization of management. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 20: 336-356. PMID 34505377 DOI: 10.1002/wps.20919  0.304
2021 Hampshire A, Hellyer PJ, Soreq E, Mehta MA, Ioannidis K, Trender W, Grant JE, Chamberlain SR. Author Correction: Associations between dimensions of behaviour, personality traits, and mental-health during the COVID-19 pandemic in the United Kingdom. Nature Communications. 12: 5047. PMID 34400652 DOI: 10.1038/s41467-021-25271-6  0.508
2021 Hampshire A, Trender W, Chamberlain SR, Jolly AE, Grant JE, Patrick F, Mazibuko N, Williams SC, Barnby JM, Hellyer P, Mehta MA. Cognitive deficits in people who have recovered from COVID-19. Eclinicalmedicine. 101044. PMID 34316551 DOI: 10.1016/j.eclinm.2021.101044  0.566
2021 Hampshire A, Hellyer PJ, Soreq E, Mehta MA, Ioannidis K, Trender W, Grant JE, Chamberlain SR. Associations between dimensions of behaviour, personality traits, and mental-health during the COVID-19 pandemic in the United Kingdom. Nature Communications. 12: 4111. PMID 34272365 DOI: 10.1038/s41467-021-24365-5  0.515
2021 Lutz NM, Chamberlain SR, Goodyer IM, Bhardwaj A, Sahakian BJ, Jones PB, Wilkinson PO. Behavioral measures of impulsivity and compulsivity in adolescents with nonsuicidal self-injury. Cns Spectrums. 1-9. PMID 33888173 DOI: 10.1017/S1092852921000274  0.333
2021 Chamberlain SR, Solly JE, Hook RW, Vaghi MM, Robbins TW. Cognitive Inflexibility in OCD and Related Disorders. Current Topics in Behavioral Neurosciences. PMID 33547598 DOI: 10.1007/7854_2020_198  0.437
2020 Castle D, Beilharz F, Phillips KA, Brakoulias V, Drummond LM, Hollander E, Ioannidis K, Pallanti S, Chamberlain SR, Rossell SL, Veale D, Wilhelm S, Van Ameringen M, Dell'Osso B, Menchon JM, et al. Body dysmorphic disorder: a treatment synthesis and consensus on behalf of the International College of Obsessive-Compulsive Spectrum Disorders and the Obsessive Compulsive and Related Disorders Network of the European College of Neuropsychopharmacology. International Clinical Psychopharmacology. PMID 33230025 DOI: 10.1097/YIC.0000000000000342  0.363
2020 Hook RW, Grant JE, Ioannidis K, Tiego J, Yücel M, Wilkinson P, Chamberlain SR. Trans-diagnostic measurement of impulsivity and compulsivity: A review of self-report tools. Neuroscience and Biobehavioral Reviews. PMID 33115636 DOI: 10.1016/j.neubiorev.2020.10.007  0.302
2020 Jalal B, Chamberlain SR, Robbins TW, Sahakian BJ. Obsessive-compulsive disorder-contamination fears, features and treatment: Novel smartphone therapies in light of global mental health and pandemics (COVID-19). Cns Spectrums. 1-35. PMID 33081864 DOI: 10.1017/S1092852920001947  0.702
2020 Lochner C, Chamberlain SR, Kidd M, Taljaard L, Fineberg NA, Robbins TW, Stein DJ. The effects of acute serotonin challenge on executive planning in patients with obsessive-compulsive disorder (OCD), their first-degree relatives, and healthy controls. Psychopharmacology. PMID 32638035 DOI: 10.1007/S00213-020-05597-7  0.357
2020 Albertella L, Le Pelley ME, Chamberlain SR, Westbrook F, Lee RSC, Fontenelle LF, Grant JE, Segrave RA, McTavish E, Yücel M. Reward-related attentional capture and cognitive inflexibility interact to determine greater severity of compulsivity-related problems. Journal of Behavior Therapy and Experimental Psychiatry. 69: 101580. PMID 32562925 DOI: 10.1016/J.Jbtep.2020.101580  0.341
2020 Shen C, Luo Q, Chamberlain SR, Morgan S, Romero-Garcia R, Du J, Zhao X, Touchette É, Montplaisir J, Vitaro F, Boivin M, Tremblay RE, Zhao XM, Robaey P, Feng J, et al. What Is the Link Between Attention-Deficit/Hyperactivity Disorder and Sleep Disturbance? A Multimodal Examination of Longitudinal Relationships and Brain Structure Using Large-Scale Population-Based Cohorts. Biological Psychiatry. PMID 32414481 DOI: 10.1016/J.Biopsych.2020.03.010  0.429
2019 Grant JE, Chamberlain SR. Gambling and substance use: Comorbidity and treatment implications. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 99: 109852. PMID 31881248 DOI: 10.1016/j.pnpbp.2019.109852  0.321
2019 Hampshire A, Zadel A, Sandrone S, Soreq E, Fineberg N, Bullmore ET, Robbins TW, Sahakian BJ, Chamberlain SR. Inhibition-Related Cortical Hypoconnectivity as a Candidate Vulnerability Marker for Obsessive-Compulsive Disorder. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 31806485 DOI: 10.1016/j.bpsc.2019.09.010  0.479
2019 Grant JE, Chamberlain SR. Neurocognitive findings in young adults with binge eating disorder. International Journal of Psychiatry in Clinical Practice. 1-6. PMID 31722589 DOI: 10.1080/13651501.2019.1687724  0.402
2019 Parkes L, Tiego J, Aquino K, Braganza L, Chamberlain SR, Fontenelle L, Harrison BJ, Lorenzetti V, Paton B, Razi A, Fornito A, Yücel M. Transdiagnostic variations in impulsivity and compulsivity in obsessive-compulsive disorder and gambling disorder correlate with effective connectivity in cortical-striatal-thalamic-cortical circuits. Neuroimage. 116070. PMID 31382045 DOI: 10.1016/J.Neuroimage.2019.116070  0.315
2019 Verbruggen F, Aron AR, Band GP, Beste C, Bissett PG, Brockett AT, Brown JW, Chamberlain SR, Chambers CD, Colonius H, Colzato LS, Corneil BD, Coxon JP, Dupuis A, Eagle DM, et al. A consensus guide to capturing the ability to inhibit actions and impulsive behaviors in the stop-signal task. Elife. 8. PMID 31033438 DOI: 10.7554/Elife.46323  0.562
2019 Ioannidis K, Hook R, Wickham K, Grant JE, Chamberlain SR. Impulsivity in Gambling Disorder and problem gambling: a meta-analysis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30986818 DOI: 10.1038/s41386-019-0393-9  0.375
2019 Chamberlain SR, Grant JE. Efficacy of Pharmacological Interventions in Targeting Decision-Making Impairments across Substance and Behavioral Addictions. Neuropsychology Review. PMID 30852805 DOI: 10.1007/s11065-019-09400-z  0.325
2019 Ioannidis K, Hook R, Goudriaan AE, Vlies S, Fineberg NA, Grant JE, Chamberlain SR. Cognitive deficits in problematic internet use: meta-analysis of 40 studies. The British Journal of Psychiatry : the Journal of Mental Science. 1-8. PMID 30784392 DOI: 10.1192/bjp.2019.3  0.342
2018 Skandali N, Rowe JB, Voon V, Deakin JB, Cardinal RN, Cormack F, Passamonti L, Bevan-Jones WR, Regenthal R, Chamberlain SR, Robbins TW, Sahakian BJ. Dissociable effects of acute SSRI (escitalopram) on executive, learning and emotional functions in healthy humans. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30305705 DOI: 10.1038/S41386-018-0229-Z  0.726
2018 Grant JE, Chamberlain SR. Salivary Inflammatory Markers in Trichotillomania: A Pilot Study. Neuropsychobiology. 1-5. PMID 29920483 DOI: 10.1159/000489865  0.307
2018 Chamberlain SR, Ioannidis K, Grant JE. The impact of comorbid impulsive/compulsive disorders in problematic Internet use. Journal of Behavioral Addictions. 1-7. PMID 29788748 DOI: 10.1556/2006.7.2018.30  0.378
2018 Chamberlain SR, Grant JE. Initial validation of a transdiagnostic compulsivity questionnaire: the Cambridge-Chicago Compulsivity Trait Scale. Cns Spectrums. 1-7. PMID 29730994 DOI: 10.1017/S1092852918000810  0.306
2017 Vaghi MM, Hampshire A, Fineberg NA, Kaser M, Brühl AB, Sahakian BJ, Chamberlain SR, Robbins TW. Hypoactivation and Dysconnectivity of a Frontostriatal Circuit During Goal-Directed Planning as an Endophenotype for Obsessive-Compulsive Disorder. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 2: 655-663. PMID 29167834 DOI: 10.1016/J.Bpsc.2017.05.005  0.748
2017 Fineberg NA, Apergis-Schoute AM, Vaghi MM, Banca P, Gillan CM, Voon V, Chamberlain SR, Eduardo C, Jemma R, Shahper S, Bullmore ET, Sahakian BJ, Robbins TW. Mapping Compulsivity in the DSM - 5 Obsessive Compulsive and Related Disorders: Cognitive Domains, Neural Circuitry And Treatment. The International Journal of Neuropsychopharmacology. PMID 29036632 DOI: 10.1093/Ijnp/Pyx088  0.551
2017 Chamberlain SR, Redden SA, Leppink E, Grant JE. Problematic internet use in gamblers: impact on clinical and cognitive measures. Cns Spectrums. 1-9. PMID 28893336 DOI: 10.1017/S1092852917000037  0.349
2017 Chamberlain SR, Stochl J, Redden SA, Odlaug BL, Grant JE. Latent class analysis of gambling subtypes and impulsive/compulsive associations: Time to rethink diagnostic boundaries for gambling disorder? Addictive Behaviors. 72: 79-85. PMID 28384607 DOI: 10.1016/j.addbeh.2017.03.020  0.355
2016 Jefferies-Sewell K, Chamberlain SR, Fineberg NA, Laws KR. Cognitive dysfunction in body dysmorphic disorder: new implications for nosological systems and neurobiological models. Cns Spectrums. 1-10. PMID 27899165 DOI: 10.1017/S1092852916000468  0.396
2016 Bandelow B, Baldwin D, Abelli M, Bolea-Alamanac B, Bourin M, Chamberlain SR, Cinosi E, Davies S, Domschke K, Fineberg N, Grünblatt E, Jarema M, Kim YK, Maron E, Masdrakis V, et al. Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-53. PMID 27419272 DOI: 10.1080/15622975.2016.1190867  0.301
2016 Leppink EW, Chamberlain SR, Grant JE. How Similar Are the Disorders Included Under the Umbrella of Obsessive-Compulsive Disorder and Related Disorders?-Reply. Jama Psychiatry. PMID 27409979 DOI: 10.1001/jamapsychiatry.2016.1452  0.312
2016 Chamberlain SR, Derbyshire KL, Leppink EW, Grant JE. Neurocognitive Deficits Associated with Antisocial Personality Disorder in Non-treatment-seeking Young Adults. The Journal of the American Academy of Psychiatry and the Law. 44: 218-225. PMID 27236178  0.374
2016 Chamberlain SR, Leppink EW, Redden SA, Grant JE. Are obsessive-compulsive symptoms impulsive, compulsive or both? Comprehensive Psychiatry. 68: 111-8. PMID 27234191 DOI: 10.1016/j.comppsych.2016.04.010  0.301
2016 Chamberlain SR, Derbyshire K, Daws RE, Odlaug BL, Leppink EW, Grant JE. White matter tract integrity in treatment-resistant gambling disorder. The British Journal of Psychiatry : the Journal of Mental Science. PMID 26846614 DOI: 10.1192/bjp.bp.115.165506  0.316
2015 van den Heuvel OA, van Wingen G, Soriano-Mas C, Alonso P, Chamberlain SR, Nakamae T, Denys D, Goudriaan AE, Veltman DJ. Brain circuitry of compulsivity. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26711687 DOI: 10.1016/J.Euroneuro.2015.12.005  0.32
2015 Lochner C, Chamberlain SR, Kidd M, Fineberg NA, Stein DJ. Altered cognitive response to serotonin challenge as a candidate endophenotype for obsessive-compulsive disorder. Psychopharmacology. PMID 26645225 DOI: 10.1007/S00213-015-4172-Y  0.402
2015 Chamberlain SR, Lochner C, Stein DJ, Goudriaan AE, Holst RV, Zohar J, Grant JE. Behavioural addiction-A rising tide? European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26585600 DOI: 10.1016/J.Euroneuro.2015.08.013  0.328
2015 Grant JE, Odlaug BL, Chamberlain SR. Neural and psychological underpinnings of gambling disorder: A review. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 65: 188-193. PMID 26497079 DOI: 10.1016/j.pnpbp.2015.10.007  0.403
2015 Grant JE, Leppink EW, Redden SA, Odlaug BL, Chamberlain SR. COMT genotype, gambling activity, and cognition. Journal of Psychiatric Research. 68: 371-6. PMID 26028545 DOI: 10.1016/j.jpsychires.2015.04.029  0.335
2015 Grant JE, Chamberlain SR. Gambling disorder and its relationship with substance use disorders: implications for nosological revisions and treatment. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 24: 126-31. PMID 25864600 DOI: 10.1111/ajad.12112  0.331
2015 Grant JE, Odlaug BL, Chamberlain SR. Reduced cortical thickness in gambling disorder: a morphometric MRI study. European Archives of Psychiatry and Clinical Neuroscience. PMID 25814469 DOI: 10.1007/s00406-015-0592-2  0.324
2014 Ioannidis K, Chamberlain SR, Müller U. Ostracising caffeine from the pharmacological arsenal for attention-deficit hyperactivity disorder--was this a correct decision? A literature review. Journal of Psychopharmacology (Oxford, England). 28: 830-6. PMID 24989644 DOI: 10.1177/0269881114541014  0.381
2014 Grant JE, Chamberlain SR. Impulsive action and impulsive choice across substance and behavioral addictions: cause or consequence? Addictive Behaviors. 39: 1632-9. PMID 24864028 DOI: 10.1016/j.addbeh.2014.04.022  0.338
2014 Fineberg NA, Chamberlain SR, Goudriaan AE, Stein DJ, Vanderschuren LJ, Gillan CM, Shekar S, Gorwood PA, Voon V, Morein-Zamir S, Denys D, Sahakian BJ, Moeller FG, Robbins TW, Potenza MN. New developments in human neurocognition: clinical, genetic, and brain imaging correlates of impulsivity and compulsivity. Cns Spectrums. 19: 69-89. PMID 24512640 DOI: 10.1017/S1092852913000801  0.515
2014 Derbyshire KL, Chamberlain SR, Odlaug BL, Schreiber LR, Grant JE. Neurocognitive functioning in compulsive buying disorder. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 26: 57-63. PMID 24501731  0.335
2014 Morein-Zamir S, Papmeyer M, Pertusa A, Chamberlain SR, Fineberg NA, Sahakian BJ, Mataix-Cols D, Robbins TW. The profile of executive function in OCD hoarders and hoarding disorder. Psychiatry Research. 215: 659-67. PMID 24467873 DOI: 10.1016/j.psychres.2013.12.026  0.593
2014 Camilla d'Angelo LS, Eagle DM, Grant JE, Fineberg NA, Robbins TW, Chamberlain SR. Animal models of obsessive-compulsive spectrum disorders. Cns Spectrums. 19: 28-49. PMID 24093759 DOI: 10.1017/S1092852913000564  0.324
2013 del Campo N, Fryer TD, Hong YT, Smith R, Brichard L, Acosta-Cabronero J, Chamberlain SR, Tait R, Izquierdo D, Regenthal R, Dowson J, Suckling J, Baron JC, Aigbirhio FI, Robbins TW, et al. A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment. Brain : a Journal of Neurology. 136: 3252-70. PMID 24163364 DOI: 10.1093/Brain/Awt263  0.48
2013 Odlaug BL, Chamberlain SR, Schreiber LR, Grant JE. Where on the obsessive impulsive-compulsive spectrum does hair-pulling disorder belong? International Journal of Psychiatry in Clinical Practice. 17: 279-85. PMID 23899226 DOI: 10.3109/13651501.2013.828079  0.321
2013 Chamberlain SR, Robbins TW. Noradrenergic modulation of cognition: therapeutic implications. Journal of Psychopharmacology (Oxford, England). 27: 694-718. PMID 23518815 DOI: 10.1177/0269881113480988  0.409
2012 Ersche KD, Turton AJ, Chamberlain SR, Müller U, Bullmore ET, Robbins TW. Cognitive dysfunction and anxious-impulsive personality traits are endophenotypes for drug dependence. The American Journal of Psychiatry. 169: 926-36. PMID 22952072 DOI: 10.1176/appi.ajp.2012.11091421  0.582
2012 Lochner C, Simmons C, Kidd M, Chamberlain SR, Fineberg NA, van Honk J, Ipser J, Stein DJ. Differential effects of escitalopram challenge on disgust processing in obsessive-compulsive disorder. Behavioural Brain Research. 226: 274-80. PMID 21963422 DOI: 10.1016/J.Bbr.2011.09.029  0.341
2012 Grant JE, Chamberlain SR, Schreiber L, Odlaug BL. Neuropsychological deficits associated with cannabis use in young adults. Drug and Alcohol Dependence. 121: 159-62. PMID 21920674 DOI: 10.1016/j.drugalcdep.2011.08.015  0.323
2011 Grant JE, Odlaug BL, Chamberlain SR. A cognitive comparison of pathological skin picking and trichotillomania. Journal of Psychiatric Research. 45: 1634-8. PMID 21824627 DOI: 10.1016/j.jpsychires.2011.07.012  0.321
2011 Del Campo N, Chamberlain SR, Sahakian BJ, Robbins TW. The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder. Biological Psychiatry. 69: e145-57. PMID 21550021 DOI: 10.1016/j.biopsych.2011.02.036  0.473
2011 Chamberlain SR, Blackwell AD, Nathan PJ, Hammond G, Robbins TW, Hodges JR, Michael A, Semple JM, Bullmore ET, Sahakian BJ. Differential cognitive deterioration in dementia: a two year longitudinal study. Journal of Alzheimer's Disease : Jad. 24: 125-36. PMID 21206003 DOI: 10.3233/JAD-2010-100450  0.489
2011 Chamberlain SR, Robbins TW, Winder-Rhodes S, Müller U, Sahakian BJ, Blackwell AD, Barnett JH. Translational approaches to frontostriatal dysfunction in attention-deficit/hyperactivity disorder using a computerized neuropsychological battery. Biological Psychiatry. 69: 1192-203. PMID 21047621 DOI: 10.1016/j.biopsych.2010.08.019  0.492
2010 Chamberlain SR, Hampshire A, Menzies LA, Garyfallidis E, Grant JE, Odlaug BL, Craig K, Fineberg N, Sahakian BJ. Reduced brain white matter integrity in trichotillomania: a diffusion tensor imaging study. Archives of General Psychiatry. 67: 965-71. PMID 20819990 DOI: 10.1001/archgenpsychiatry.2010.109  0.417
2010 Chamberlain SR, Grant JE, Costa A, Müller U, Sahakian BJ. Effects of acute modafinil on cognition in trichotillomania. Psychopharmacology. 212: 597-601. PMID 20714709 DOI: 10.1007/s00213-010-1981-x  0.508
2010 Fineberg NA, Potenza MN, Chamberlain SR, Berlin HA, Menzies L, Bechara A, Sahakian BJ, Robbins TW, Bullmore ET, Hollander E. Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 591-604. PMID 19940844 DOI: 10.1038/Npp.2009.185  0.495
2009 Chamberlain SR, Menzies L. Endophenotypes of obsessive-compulsive disorder: rationale, evidence and future potential. Expert Review of Neurotherapeutics. 9: 1133-46. PMID 19673603 DOI: 10.1586/ern.09.36  0.312
2009 Chamberlain SR, Odlaug BL, Boulougouris V, Fineberg NA, Grant JE. Trichotillomania: neurobiology and treatment. Neuroscience and Biobehavioral Reviews. 33: 831-42. PMID 19428495 DOI: 10.1016/j.neubiorev.2009.02.002  0.305
2009 Clark L, Chamberlain SR, Sahakian BJ. Neurocognitive mechanisms in depression: implications for treatment. Annual Review of Neuroscience. 32: 57-74. PMID 19400725 DOI: 10.1146/annurev.neuro.31.060407.125618  0.496
2009 Chamberlain SR, Hampshire A, Müller U, Rubia K, Del Campo N, Craig K, Regenthal R, Suckling J, Roiser JP, Grant JE, Bullmore ET, Robbins TW, Sahakian BJ. Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study. Biological Psychiatry. 65: 550-5. PMID 19026407 DOI: 10.1016/J.Biopsych.2008.10.014  0.627
2008 Chamberlain SR, Menzies LA, Fineberg NA, Del Campo N, Suckling J, Craig K, Müller U, Robbins TW, Bullmore ET, Sahakian BJ. Grey matter abnormalities in trichotillomania: morphometric magnetic resonance imaging study. The British Journal of Psychiatry : the Journal of Mental Science. 193: 216-21. PMID 18757980 DOI: 10.1192/Bjp.Bp.107.048314  0.437
2008 Chamberlain SR, Menzies L, Hampshire A, Suckling J, Fineberg NA, del Campo N, Aitken M, Craig K, Owen AM, Bullmore ET, Robbins TW, Sahakian BJ. Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science (New York, N.Y.). 321: 421-2. PMID 18635808 DOI: 10.1126/Science.1154433  0.492
2008 Menzies L, Williams GB, Chamberlain SR, Ooi C, Fineberg N, Suckling J, Sahakian BJ, Robbins TW, Bullmore ET. White matter abnormalities in patients with obsessive-compulsive disorder and their first-degree relatives. The American Journal of Psychiatry. 165: 1308-15. PMID 18519525 DOI: 10.1176/Appi.Ajp.2008.07101677  0.461
2008 Menzies L, Chamberlain SR, Laird AR, Thelen SM, Sahakian BJ, Bullmore ET. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neuroscience and Biobehavioral Reviews. 32: 525-49. PMID 18061263 DOI: 10.1016/J.Neubiorev.2007.09.005  0.505
2007 Menzies L, Achard S, Chamberlain SR, Fineberg N, Chen CH, del Campo N, Sahakian BJ, Robbins TW, Bullmore E. Neurocognitive endophenotypes of obsessive-compulsive disorder. Brain : a Journal of Neurology. 130: 3223-36. PMID 17855376 DOI: 10.1093/brain/awm205  0.494
2007 Chamberlain SR, Del Campo N, Dowson J, Müller U, Clark L, Robbins TW, Sahakian BJ. Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder. Biological Psychiatry. 62: 977-84. PMID 17644072 DOI: 10.1016/j.biopsych.2007.03.003  0.506
2007 Chamberlain SR, Robbins TW, Sahakian BJ. The neurobiology of attention-deficit/hyperactivity disorder. Biological Psychiatry. 61: 1317-9. PMID 17556026 DOI: 10.1016/j.biopsych.2007.04.009  0.496
2007 Chamberlain SR, Müller U, Cleary S, Robbins TW, Sahakian BJ. Atomoxetine increases salivary cortisol in healthy volunteers. Journal of Psychopharmacology (Oxford, England). 21: 545-9. PMID 17446206 DOI: 10.1177/0269881106075274  0.444
2007 Chamberlain SR, Sahakian BJ. The neuropsychiatry of impulsivity. Current Opinion in Psychiatry. 20: 255-61. PMID 17415079 DOI: 10.1097/YCO.0b013e3280ba4989  0.541
2007 Chamberlain SR, Menzies L, Sahakian BJ, Fineberg NA. Lifting the veil on trichotillomania. The American Journal of Psychiatry. 164: 568-74. PMID 17403968 DOI: 10.1176/appi.ajp.164.4.568  0.304
2007 Chamberlain SR, Müller U, Deakin JB, Corlett PR, Dowson J, Cardinal RN, Aitken MR, Robbins TW, Sahakian BJ. Lack of deleterious effects of buspirone on cognition in healthy male volunteers. Journal of Psychopharmacology (Oxford, England). 21: 210-5. PMID 17329302 DOI: 10.1177/0269881107068066  0.756
2007 Chamberlain SR, Fineberg NA, Menzies LA, Blackwell AD, Bullmore ET, Robbins TW, Sahakian BJ. Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive-compulsive disorder. The American Journal of Psychiatry. 164: 335-8. PMID 17267798 DOI: 10.1176/appi.ajp.164.2.335  0.554
2007 Stein DJ, Chamberlain SR, Fineberg N. An A-B-C model of habit disorders: hair-pulling, skin-picking, and other stereotypic conditions. Cns Spectrums. 11: 824-7. PMID 17075554 DOI: 10.1017/S1092852900014978  0.335
2007 Chamberlain SR, Fineberg NA, Blackwell AD, Clark L, Robbins TW, Sahakian BJ. A neuropsychological comparison of obsessive-compulsive disorder and trichotillomania. Neuropsychologia. 45: 654-62. PMID 17005210 DOI: 10.1016/j.neuropsychologia.2006.07.016  0.547
2006 Chamberlain SR, Sahakian BJ. The neuropsychology of mood disorders. Current Psychiatry Reports. 8: 458-63. PMID 17162825  0.576
2006 Chamberlain SR, Müller U, Robbins TW, Sahakian BJ. Neuropharmacological modulation of cognition. Current Opinion in Neurology. 19: 607-12. PMID 17102701 DOI: 10.1097/01.wco.0000247613.28859.77  0.485
2006 Chamberlain SR, Fineberg NA, Blackwell AD, Robbins TW, Sahakian BJ. Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania. The American Journal of Psychiatry. 163: 1282-4. PMID 16816237 DOI: 10.1176/appi.ajp.163.7.1282  0.55
2006 Chamberlain SR, Müller U, Blackwell AD, Robbins TW, Sahakian BJ. Noradrenergic modulation of working memory and emotional memory in humans. Psychopharmacology. 188: 397-407. PMID 16642355 DOI: 10.1007/s00213-006-0391-6  0.351
2006 Chamberlain SR, Müller U, Blackwell AD, Clark L, Robbins TW, Sahakian BJ. Neurochemical modulation of response inhibition and probabilistic learning in humans. Science (New York, N.Y.). 311: 861-3. PMID 16469930 DOI: 10.1126/science.1121218  0.45
2006 Chamberlain SR, Blackwell AD, Fineberg NA, Robbins TW, Sahakian BJ. Strategy implementation in obsessive-compulsive disorder and trichotillomania. Psychological Medicine. 36: 91-7. PMID 16202188 DOI: 10.1017/S0033291705006124  0.504
2004 Chamberlain SR, Sahakian BJ. Cognition in mania and depression: psychological models and clinical implications. Current Psychiatry Reports. 6: 451-8. PMID 15538994  0.568
Show low-probability matches.